In pain years, I am ancient

http://www.businessinsider.com/is-a-dog-year-equal-to-7-human-years-2014-10

Compared to humans, dogs age more quickly at the beginning of their lives and slower toward the end. Therefore, calculating your dog’s age relative to yours is a bit tricky, but luckily it’s possible…  Although the origins of the seven-year myth is unknown, people have been trying to find a good way to calculate dog years in human years since the 1200s. One of the earliest examples of this is an inscription at Westminster Abbey that dates to the year 1268 and calculates that one human year is equivalent to nine dog years, which was part of some strange way to calculate the end of the world in the 1200s…

How do we calculate pain years compared to those that are not?  How would you compare one year of a chronic pain patient’s life to that of someone who isn’t in constant pain?  As a pain patient, do I live two years for every average year?  Or is it three or four years?

Nobody knows. All I know is that, in pain years, I am ancient.  Living in pain slows time to a crawl, and I feel like I’ve lived three lifetimes already.  Poor, weary, ancient me. 🙂

5/15/2014, Cancer patients being denied medications by pharmacists

http://www.jrn.com/ktnv/news/contact-13/contact-13-investigates/Patients-being-denied-medications-259444711.html?lc=Tablet

One cancer patient was denied her pain medication shortly before she died.  When Rose Chamberlain passed away her husband, Carl, lost the love of his life, “My wife was all I had.”

Quality of life is all Carl wanted for his wife last Christmas, “All Christmas Eve and all Christmas Day, she was in pain, screaming in pain.”

“Now they’re hitting us where it really hurts, which is the patients,” said Dr. James Sanchez an Oncologist with Comprehensive Cancer Centers of Nevada. He’s seen several cancer patients experience this problem… He and his colleagues don’t know what to make of pharmacies denying their pain pill prescriptions.

Don’t know what to make of the medical industry deciding to join the drug war and criminalize pain patients?  Did cancer doctors think their patients wouldn’t be affected?

After all, he explains, opiates were designed to treat cancer patients, “In order to provide them with a good quality of life, we have to provide them with relief of their pain.”

Only cancer patients deserve relief from their pain and a good quality of life?

Rose finally got her pain pills after the holiday, but with the next refill it was more denials and delays at other Walgreens locations, CVS and Target.

“When people refused to call the doctor, when they lie to your face, that hurts a lot,” said Carl as tears ran down his face. “Especially when you know your wife is dying and you just want her to have a little relief from the pain. Just wanted to be treated with dignity and respect.”

David Wuest is Deputy Secretary of the Nevada State Board of Pharmacy, “Right now there’s less meds being manufactured. There’s less meds that are being shipped to pharmacies. And there are patients that unfortunately, that may be going without medicines.”

Less meds being manufactured = DEA, controlling the supply.

If you’re being denied or delayed, the Board of Pharmacy recommends you go back to your doctor. Also, while under state law the board cannot require a pharmacist to fill a prescription, they will try to help patients having problems.

You can call the state Board of Pharmacy at (800) 364-2081.

We contacted the pharmacy chains where Carl said he ran into these problems. Both Walgreens and CVS refused our requests for an on-camera interview…

1/15/2015, Innovative kids’ pain clinic opens in Twin Cities

https://www.facebook.com/pages/Opposition-to-Kentucky-HB-1-Reform-HB-217-aka-Pill-Mill-Bill/595049517218134

http://www.kare11.com/story/news/health/2015/01/15/innovative-kids-pain-clinic-opens-in-twin-cities/21828461/

The ten thousand square foot clinic was made possible by donations, the most sizeable, coming from the late Aveda founder, Horst Rechelbacher.

He and his wife gave 1.5 million to the 2 million dollar project, so the clinic, is in their name…

The clinic houses a massage and acupuncture room, and floor to ceiling it is covered with sensory soothing photos of Minnesota native plants and trees, ambient sounds of loons and wildlife kiss the air.

The floors are made from local wood and are designed to absorb noise to take away the anxiety sounds of bustling feet; always keeping in mind that this is to be a soothing space for children with chronic pain or who are getting end of life palliative care…

Champion Pain Care Corporation (CPAI) Is Pursuing the $4 Billion Pain Management Market

http://www.releasewire.com/press-releases/release-576261.htm

-New restrictions on opioids that make the proprietary Champion Pain Care Protocol (“the Protocol”), a non-pharmaceutical treatment plan licensed to the Company that is highly effective in reducing pain, attractive to patients, doctors and funding agencies.

CORPORATE OFFICE:
48 Wall Street, 10th Floor,
New York, NY 10005
MAIN 775-546-0311
info@championpaincare.com

http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=CPAI

Champion Pain Care Corporation, a development stage company, operates as a pain management company. It offers the Champion Pain Care Protocol, a proprietary pain management protocol for the treatment and management of chronic pain, as well as other pain management treatments. The company’s protocol includes various treatment plans comprising physical examination by the attending doctor, blood testing, and urine drug screening; education for patients about the nature of their chronic pain; on-going interaction to support patient adherence to beneficial behavioral changes; relaxation training to reduce the effects or stress and anxiety, which can aggravate pain; amino acids and other dietary supplements to restore and maintain normal brain chemistry; and the reduction of cellular and joint inflammation. Its treatment plans also consists of the day and night time regimens to promote restorative sleep; use of electrotherapy stimulation to promote production and release of endorphin; topical medications for pain relief; and on-going counseling, telephone and on-line support, and checkups. The company was formerly known as OICCO Acquisition I, Inc. and changed its name to Champion Pain Care Corporation in August 2014. The company is based in New York, New York. Champion Pain Care Corporation is a subsidiary of Champion Care Corp.

http://www.sec.gov/Archives/edgar/data/1469284/000138713113003904/ex10-5.htm

LICENSE AGREEMENT dated as of February 1, 2013, between Champion Care Corp. (“Licensor”), a corporation incorporated under the laws of Ontario, Canada having its principal place of business at 307-208 Evans Avenue, Toronto, Ontario, Canada M8Z 1J7 and Champion Pain Care Corp. (“Licensee”), a Nevada corporation having its principal place of business at 123 West Nye Lane, Suite 129, Carson City, Nevada 89706.

http://quotes.wsj.com/BOVKF/company-people/executive-profile/16281331

Terrance George Owen, 68
Chairman, Bi-Optic Ventures, Inc.

Dr. Terrance G. Owen is Independent Director at Eastwood Bio-Medical Canada, Inc., Chief Executive Officer, CFO, Director & CAO at OICco Acquisition I, Inc., Independent Director at Pacific Paradym Energy, Inc., Chief Executive Officer at Nanotech Systems, Inc., Independent Director at Pacific Arc Resources Ltd., Independent Director at Sonoma Resources, Inc., Chairman at Bi-Optic Ventures, Inc., and Chief Executive Officer & Director at Champion Pain Care Corp. He is on the Board of Directors at Eastwood Bio-Medical Canada, Inc., OICco Acquisition I, Inc., Pacific Paradym Energy, Inc., Pacific Arc Resources Ltd., Sonoma Resources, Inc., Champion Care Corp., and Champion Pain Care Corp.

Dr. Owen was previously employed as President, Chief Executive Officer & Director by Vanc Pharmaceuticals, Inc., President & Director by Helix BioPharma Corp., and President by Helix Biotech Corp.

Google:

Nuvapharm | Pharmaceutical Inc.
http://www.nuvapharm.com/
This site may harm your computer.
Nuvapharm has changed it’s company name to Vancpharm. This page will automatically be redirected to our new company website http://www.vancpharm.com.

http://www.bloomberg.com/research/stocks/ownership/ownership.asp?ticker=NPH:CN

Vanc Pharmaceuticals Inc (NPH:Venture)

VANC Pharmaceuticals Receives NPNs from Health Canada for 4 Products
Nov 19 14
VANC Pharmaceuticals Inc. announced that it has received Natural Product Number (the “NPN”) approvals for: FerroHEME (heme-iron supplement), PEDIA-SAFE drops (multivitamin dietary supplement for infant and children), SennaLax (natural laxative) and T36 Ointment (disinfectant and corticosteroid). The NPN approvals allow Vanc to manufacture, market and sell all 4 products immediately. The Canadian market for these 4 products is estimated to be $90 million annually. Vanc plans to manufacture these products and start sales and marketing activities for them beginning in Q1-2015. FerroHEME-A natural, bio-identical and highly bio-available organic haemoglobin iron supplement. PEDIA-SAFE-Drops a liquid multivitamin dietary supplement scientifically formulated for infants and children to promote and ensure the optimal physiological growth and development. SennaLax -A stimulant laxative derived from Senna leaves for gentle, overnight relief of occasional constipation. T36 Ointment -An ointment for temporary relief of minor skin irritations, rashes, itching and redness due to eczema, insect bites, poison ivy, poison oak, poison sumac, contact dermatitis, seborrheic dermatitis, psoriasis.

Vanc Pharmaceuticals Inc. Receives Health Canada Approval for 22 Generic Molecules
Nov 18 14
Vanc Pharmaceuticals Inc. announced that it has received Notice of Compliance from Health Canada for 22 generic molecules. These 22 molecules will comprise of 51 dosage forms across various therapeutic categories; including both chronic (long term) therapy and acute (short term) therapy. The Notice of Compliance from Health Canada provides the authorization for Vanc to market and sell the generic molecules in Canada.

Vanc Pharmaceuticals Inc. Auditor Raises ‘Going Concern’ Doubt
Oct 28 14
Vanc Pharmaceuticals Inc. filed its Annual on Oct 28, 2014 for the period ending Jun 30, 2014. In this report its auditor, Meyers Norris Penny LLP – MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.